Overview
MoldCo has raised $8M in a Seed round on Sep 18, 2025, with participation from Cantos. The company get your health back from mold. The round will be used to accelerate product development, expand the team, and scale go-to-market operations.
Operating in the public health sector, MoldCo is positioned to capitalize on growing demand for innovative solutions in this space. With fresh capital, the company is expected to invest heavily in R&D and talent acquisition, signaling a period of aggressive growth ahead.
Market Outlook
This funding positions MoldCo as one to watch in the public health landscape. As the company scales, it will likely become an increasingly attractive partner — and customer — for B2B vendors looking to sell into well-funded, growth-stage companies. The post-raise window of 60-90 days is typically when startups are most receptive to new tools, services, and partnerships.
Why contact MoldCo now
MoldCo just closed $8M in Seed funding — which means they're actively scaling their team, upgrading their tech stack, and looking for vendors who can help them move fast. Companies at this stage typically make purchasing decisions within 60-90 days of closing a round. If you sell to public health companies, this is your window to reach out before competitors do.
Founders & Contacts
Investors
Company Facts
| Company | MoldCo |
| Amount Raised | $8M |
| Funding Round | Seed |
| Date Raised | Sep 18, 2025 |
| Founded | 2023 |
| Industry | Public Health |
| Founders |
Get Verified Founder Emails
Access verified email addresses and contact details for MoldCo's founders and thousands of other funded startups.
Start Free Trial